The QualityStocks Daily Stock List
- Ucore Rare Metals, Inc. (UURAF)
- Amplify Energy Corp. (AMPY)
- Enthusiast Gaming Holdings, Inc. (EGHIF)
- LandStar, Inc. (LDSR)
- MariMed, Inc. (MRMD)
- Maverick Technology Solutions (MVRK)
- Medicenna Therapeutics Corp. (MDNAF)
- Anvia Holdings Corporation (ANVV)
- ZIVO Bioscience, Inc. (ZIVO)
- Almost Never Films, Inc. (HLWD)
- NewBridge Global Ventures, Inc. (NBGV)
- Esports Entertainment Group, Inc. (GMBL)
- First Foods Group, Inc. (FIFG)
- Cell Source, Inc. (CLCS)
Ucore Rare Metals, Inc. (UURAF)
Streetwise Reports, Micro Small Cap, Stockhouse, Street Register, Trading View, Northern Miner, and Wallet Investor reported previously on Ucore Rare Metals, Inc. (UURAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Ucore Rare Metals, Inc. engages in the exploration and separation of rare earth elements in Canada and the United States. Ucore is a development-phase company focused on rare metals resources, extraction and beneficiation technologies with near term potential for production, growth and scalability. The Company has a 100 percent ownership stake in Bokan-Dotson Ridge (Bokan). Bokan is the highest grade heavy rare earth project within the United States based on NI 43-101 standards. Ucore Rare Metals is based in the Province of Nova Scotia.
Ucore’s vision and plan is to transition to become a top nanotechnology company that provides mineral separation products and services to the mining and mineral extraction industry. Its vision includes the development of a Strategic Metals Complex in Ketchikan, Alaska and the development of its rare earth minerals property at Bokan Mountain in Alaska.
On March 31, 2014, Ucore Rare Metals announced the unanimous support of the Alaska State Legislature for Senate Bill 99 (2014) that authorized the AIDEA to issue up to USD $145 Million in bonds for the infrastructure and construction costs of the Bokan-Dotson Ridge Rare Earth Project. The Bokan Project is Ucore’s principal focus. The Project is 60 km southwest of Ketchikan, Alaska and 140 km northwest of Prince Rupert, British Columbia. It has direct ocean access to the western seaboard and the Pacific Rim.
Concerning the Ray Mountains, Alaska Project, Ucore Rare Metals, via a wholly-owned operating subsidiary, holds claims on land chosen for its mineral resource potential by the State of Alaska as part of Alaska’s land entitlement under the 1958 Alaska Statehood Act. Ucore is planning expanded exploration once title transfer is tentatively approved by the federal government.
Pertaining to Ucore’s SuperLig®-One pilot plant project, it has been engineered to accept a Pregnant Leach Solution (PLS). The initial output products are carbonate salts of the critical rare earth elements dysprosium, europium and terbium derived from the Bokan Dotson-Ridge Heavy REE Project in Southeast Alaska.
Last month, Ucore Rare Metals commended the White House for its five presidential determinations issued July 22, 2019, concluding that domestic rare earth processing capabilities are essential to national defense. The Determinations identify shortfalls in the entire REE supply chain in the U.S. Particularly, these include the capacity of separation and processing of Heavy Rare Earth Elements and Light Rare Earth Elements to meet the needs of modern U.S. military platforms. These are capabilities that Ucore Rare Metals is in the advanced stages of establishing on U.S. soil.
Pat Ryan, Chairman of Ucore Rare Metals, said, "Ucore has spent several years preparing for the events now unfolding in the U.S. REE market. The Company is well positioned to satisfy the needs of U.S. defense and commercial markets by installing REE separation and processing capabilities in Alaska, secured by our prime critical minerals project at Bokan-Dotson Ridge.”
Ucore Rare Metals, Inc. (UURAF), closed Monday's trading session at $0.1465, off by 3.2876%, on 19,300 volume with 12 trades. The average volume for the last 3 months is 305,363 and the stock's 52-week low/high is $0.064999997/$0.25.
Amplify Energy Corp. (AMPY)
Zacks, 4-Traders, Morningstar, Simply Wall St, Market Screener, and Wallet Investors reported previously on Amplify Energy Corp. (AMPY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Amplify Energy Corp. is an independent oil and natural gas company headquartered in Houston, Texas. It engages in the acquisition, development, exploration and production of oil and natural gas properties. Its properties consist of mature, legacy oil and natural gas fields. The Company previously went by the name Memorial Production Partners LP. It changed its corporate name to Amplify Energy Corp. in May of 2017.
Amplify Energy’s operations are focused in the Rockies, offshore California, East Texas/North Louisiana and South Texas. The Company’s emphasis is maintaining production across its high-quality asset base and executing on its strategic priorities.
Amplify’s properties primarily consist of operated working interests (WIs) in producing and undeveloped leasehold acreage and in identified producing wells in North America. Furthermore, the Company owns non-operated WIs in producing and undeveloped leasehold acreage. The majority of its oil and natural gas properties are located in large, mature oil and natural gas reservoirs with well-known geologic characteristics and long-lived, predictable production profiles and modest capital requirements.
Amplify Energy and Midstates Petroleum Company, Inc. (MPO) announced this past May that they entered into a definitive merger agreement pursuant to which Amplify Energy will merge with a subsidiary of Midstates in an all-stock merger-of-equals. Midstates Petroleum Company is an independent exploration and production company. It focuses on the application of modern drilling and completion techniques in oil- and liquids-rich basins in the onshore U.S. Its operations are currently centered on oilfields in the Mississippian Lime play in Oklahoma.
Last week, Amplify Energy and Midstates Petroleum Company announced that the earlier announced all-stock, merger-of-equals transaction closed. Under the terms of the merger, Amplify Energy stockholders will receive 0.933 shares of newly issued Midstates Petroleum common stock for each Amplify Energy share of common stock. Immediately following the effective time of the merger, current Midstates and Amplify stockholders, collectively, are expected to each own about 50 percent of the outstanding common stock of the combined company.
During Q2 2019, Amplify Energy generated daily production of 21.1 MBoe/d, versus midpoint guidance of 21.4 MBoe/d. Net cash provided by operating activities was $22 million for the quarter, versus the midpoint of guidance of $17 million.
Amplify Energy Corp. (AMPY), closed Monday's trading session at $5.74, up 1.4134%, on 317,062 volume with 2,547 trades. The average volume for the last 3 months is 24,924 and the stock's 52-week low/high is $4.01000022/$13.2299995.
Enthusiast Gaming Holdings, Inc. (EGHIF)
Street Signals, Stockwatch, GlobeNewswire, OTC Markets, Wallet Investor, Trading View, MicroSmallCap, Stockhouse, InvestorsHub, Seeking Alpha, Market Screener, and GuruFocus reported previously on Enthusiast Gaming Holdings, Inc. (EGHIF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Enthusiast Gaming Holdings, Inc. is the fastest-growing online community of video gamers. The Company is one of the largest vertically integrated video gaming media companies in North America. It has a platform of manifold owned and affiliated websites. At present, the Company reaches more than 150 million monthly visitors with its unique and curated content and YouTube visitors. OTCQB-listed and established in 2014, Enthusiast Gaming Holdings is based in Toronto, Ontario.
The Company focuses on building the largest network of authentic gaming enthusiasts through events, original content, and advertising. In addition, Enthusiast Gaming owns and operates Canada’s largest gaming expo, Enthusiast Gaming Live Expo, EGLX, (eglx.ca) with greater than 55,000 people attending in 2018.
Enthusiast Gaming’s inventive growth strategy adds to the website monetization potential that powers its platforms and partners. The Company is currently generating greater than one billion ad requests per week through Enthusiast Gaming Media and affiliated partners.
Last week, Enthusiast Gaming Holdings announced that it entered into a marketing agreement with Evolve ETF to provide marketing strategy and consultation, integrated advertising, and content solutions across Enthusiast Gaming’s online network and events to promote Evolve’s HERO esports index. HERO is Canada’s first esports ETF. The design of it is to provide investors with access to equity securities of companies in the video game industry.
With this Agreement, Enthusiast Gaming will launch a year-long advertising campaign for Evolve across its Canadian inventory of digital advertising solutions on its network of websites. Enthusiast Gaming will also create advertising editorials and content via its newest website, GamingStreet.com, launched to inform and educate investors about the video gaming industry.
Additionally, last week, J55 Capital Corp. and Enthusiast Gaming Holdings provided an update on the qualifying transaction and merger. J55 Capital and Enthusiast Gaming announced that further to the press release issued on May 31, 2019, J55 received conditional approval from the TSX Venture Exchange for its proposed Qualifying Transaction with Aquilini GameCo, Inc. J55 has agreed to acquire all of the issued and outstanding securities of GameCo (a wholly owned subsidiary of J55). Furthermore, J55 Capital and Enthusiast Gaming received conditional approval from the Exchange for their proposed merger by plan of arrangement. J55 will acquire all outstanding common shares of Enthusiast Gaming.
Enthusiast Gaming Holdings, Inc. (EGHIF), closed Monday's trading session at $1.125, off by 0.177462%, on 1,905 volume with 7 trades. The average volume for the last 3 months is 14,419 and the stock's 52-week low/high is $0.611699998/$1.38999998.
LandStar, Inc. (LDSR)
Silicon Investor, Zacks, Street Insider, Simply Wall St, TipRanks, Stockhouse, Stockwatch, InvestorsHub, an OTC Markets reported previously on LandStar, Inc. (LDSR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
LandStar, Inc. is the parent company of Data443™ Risk Mitigation, Inc., a top data security and privacy company. By way of its wholly-owned subsidiary DATA443™ Risk Mitigation, LandStar enables secure data - across local devices, network, cloud, and databases - at rest and in-flight. Its products and services are central to cyber data security, GDPR, compliance, as well as governance capabilities. LandStar is based in Raleigh, North Carolina and the Company lists on the OTC Markets.
LandStar’s product suite includes ArcMail, a leading provider of simple, secure and cost-effective email and enterprise archiving and management solutions. In addition, the Company’s products include ARALOC™, a market leading secure, cloud-based platform for the management, protection and distribution of digital content to the desktop and mobile devices that protects an organization’s confidential content and intellectual property (IP) assets from leakage - malicious or accidental - without impacting collaboration between all stakeholders.
Landstar’s products also include the WordPress GDPR Framework with greater than 20,000 active users. It enables organizations of all sizes to comply with the GDPR and other privacy frameworks. Moreover, products include The Virtual Data Protection Officer program, which offers a turnkey and outsourced DPO capability for smaller organizations; and, Data443™ Privacy Manager that enables the full lifecycle of Data Privacy Access Requests, Remediation, Monitoring and Reporting.
Furthermore, Landstar’s products include ClassiDocs™, the Company’s award-winning data classification and governance technology, which supports CCPA, LGPD and GDPR compliance; and ClassiDocs™ for Blockchain that provides an active implementation for the Ripple XRP, which protects blockchain transactions from inadvertent disclosure and data leaks.
Recently, LandStar announced continued momentum in its product line. This is with the addition of high-profile new data sources to enable in CCPA, GDPR, eDiscovery, archiving and data retention requirements. The growing platform list of integrations include support for top social media channels including Twitter, Facebook, Instagram and LinkedIn. These platforms are abounding with potential privacy information. They have a large part to play in any litigation response.
ArcMail recently released its Hybrid Cloud/On-Premise Software Subscription service. With it, customers can search quicker, store smarter, and protect better in light of increasing data privacy and compliance requirements. For highly-regulated industries, ArcMail’s Hybrid Cloud/On-Premise Software Subscription service enables the organization to take advantage of a subscription-based service for full and continuous coverage. This is while lessening IT (Information Technology) burden and spend.
LandStar, Inc. (LDSR), closed Monday's trading session at $0.0006, even for the day, on 21,603,170 volume with 20 trades. The average volume for the last 3 months is 23,935,896 and the stock's 52-week low/high is $0.000399999/$0.0118.
MariMed, Inc. (MRMD)
Micro Small Cap, NIC Investors, Equity Clock, Daily Marijuana Observer, CannabisNewsWire, Stock of the Week, CannabisMarketCap, Super Stock Screener, Stockhouse, PotStockNews, Morningstar, Profit Confidential, and Trading View reported earlier on MariMed, Inc. (MRMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.
MariMed, Inc. is a leading multi-state cannabis operator focused on health and wellness. Its dedication is to improving health and wellness with the highest quality hemp and cannabis products. The Company offers a complete range of cannabis products and operates state-of-the-art cannabis dispensaries in six States. Additionally, MariMed has a separate division, MariMed Hemp, focused on the development of industrial hemp-derived CBD (cannabidiol) products. OTCQB-listed, MariMed is based in Norwood, Massachusetts.
MariMed is a first mover into the hemp CBD market. It has supply and products in the U.S. and the European Union (EU). The Company’s focus is the continuing discovery of better wellness through cannabis and hemp. Its platform consists of a vertically integrated approach.
Regarding its brands and products, MariMed starts with a quality growing medium, rich genetics, and natural nutrients to formulate products for differing speeds and methods of delivery. The Company’s products always include a wide array of dosing preferences and rich terpene profiles.
Concerning Seed-to-Sale, MariMed has extensive experience with the wide assortment of issues relevant to legal cannabis business activities. This includes licensing for cultivation, processing and dispensing, litigation, banking and finance, raising and deploying capital, protecting intellectual property (IP), real estate development and leasing, and additional clickthroughs.
MariMed holds 13 cannabis licenses for cultivation, production and dispensaries across 6 U.S. States. The Company is currently managing more than 300,000 square feet of first-rate cannabis facilities. The Company also supports research and physician education, supported by the Scientific Advisory Board.
Today, MariMed reported record results for the three and six month periods ended June 30, 2019. Results reflect consistent growth in its cannabis businesses and momentum in its MariMed Hemp subsidiary, which posted significant initial transactions during Q2. For Q2 2019, Revenues increased 774.0 percent to $25.7 million. Revenue from its cannabis business grew 24.5 percent to $3.7 million.
MariMed’s Gross Profit was up 341.1 percent to $8.9 million. The Company’s Net Income increased to $4.7 million. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) totaled $6.0 million.
Subsequent to the close of Q2, MariMed announced a licensing agreement with Denver-based Binske. This agreement is to distribute its popular and varied cannabis products in a number of important markets east of the Mississippi.
MariMed holds a 33.5 percent stake in GenCanna Global. GenCanna is a Kentucky-based national leader in seed-to-sale of GMP-quality, hemp-derived CBD. MariMed’s MariMed Hemp CBD-focused subsidiary delivered its first services revenues, the first in a series of sales of hemp seeds to GenCanna Global valued at $25.2 million, with $22.0 million recognized in Q2. Subsequent to the end of Q2, the Company completed a second round of hemp seed sales to GenCanna totaling $8.0 million.
Furthermore, in Q2, MariMed acquired a minority interest in Terrace, Inc. Terrace is a Canadian-based operator. Terrace focuses on the acquisition and development of global cannabis assets in Europe and South America.
MariMed, Inc. (MRMD), closed Monday's trading session at $1.67, off by 2.907%, on 898,675 volume with 689 trades. The average volume for the last 3 months is 271,506 and the stock's 52-week low/high is $1.21000003/$5.80000019.
Maverick Technology Solutions (MVRK)
Research Pool, Investors Hangout, OTC Markets, Penny Stock Hub, Biz Journals, News to Watch, OTC.Watch, Stockopedia, InvestorsHub, Stockhouse, Trading View, Wallet Investor, and GlobeNewswire reported beforehand on Maverick Technology Solutions (MVRK), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Maverick Technology Solutions is the manufacturer of the highly acclaimed ROSINBOMB™ line of extraction presses and technology. The Company has greater than three years operating history developing and producing the ROSINBOMB™ line of rosin presses and accessories for extracting organic concentrates. ROSINBOMB presses require no chemicals or additional hardware to operate. Maverick Technology Solutions is based in Phoenix, Arizona.
Maverick established as a family business with deep roots in creating press technology for the organic fruit and vegetable juice market. ROSINBOMB presses are plug and play out of the box. The technology utilizes granted patent and patent pending techniques to optimize extraction processes and allow the user the ability to easily produce naturally-extracted, organic concentrates.
ROSINBOMB presses are manufactured to be the premier quality presses available today. Maverick Technology Solutions’ stainless steel, fully electric and patent-pending technology delivers 5,000+ lbs of pressure. The design is to ensure the highest possible yield.
Maverick also has its Flow Channel Technology™. This technology enables processors to produce large volumes of solventless extracts exclusively using heat and pressure. The frictionless Flow Channel Technology™ is a significant leap ahead in extract production at a fraction of the cost of existing solvent-based systems.
In July, Maverick Technology Solutions announced the recent patent filing of its pioneering Flow Channel Technology™. Mr. Ryan Mayer, Inventor and President of Maverick Technology Solutions, said, “By advancing forward the existing technology that has propelled ROSINBOMB to become the leader in solventless extract production, we were able to develop our Flow Channel Technology™ to make solvent free mass production a reality. This combined with the added advantage of removing the use of parchment and eliminating manual collecting from the equation, undoubtedly delivers the industry the preeminent solution to manufacturing the highest quality clean extracts at an unparalleled cost.”
In late July, Maverick Technology Solutions announced the issuance of US Design Patent No. D854,064 S. This patent illustrates and validates ROSINBOMB’s innovative design and technical implementation that ensures the entire line of extraction presses are equal in elegance and functionality. This design patent is issued for the market leading Rosinbomb™ M Series product line. Maverick has also filed for Patents on its critically acclaimed consumer targeted Rosinbomb Rocket in the fall of 2018 and the above-mentioned Flow Channel Technology™ in June of this year.
Maverick Technology Solutions (MVRK), closed Monday's trading session at $1.43, even for the day, on 100 volume. The average volume for the last 3 months is 1,215 and the stock's 52-week low/high is $0.245000004/$2.0999999.
Medicenna Therapeutics Corp. (MDNAF)
InvestorX, Stock Twits, Invest Tribune, Penny Stock Hub, The Venture Report, Zacks, Stock Pulse, and OTC Markets reported beforehand on Medicenna Therapeutics Corp. (MDNAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company listed on the OTCQB. It concentrates on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad variety of cancers. Medicenna Therapeutics has its corporate office in Toronto, Ontario.
The Company is developing a unique set of tunable Superkines™. These can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment, and cancer stem cells without harming healthy cells.
Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna Therapeutics’ lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the U.S. MDNA55 has been studied in five clinical trials involving 132 patients. This includes 112 adults with rGBM.
MDNA55 targets Temodar-resistant tumors. Delivery by CED infusion of MDNA55 bypasses the BBB (Blood Brain Barrier). Precision delivery attains high doses without systemic exposure. MDNA55 has demonstrated compelling efficacy. In addition, MDNA55 has obtained Fast-Track and Orphan Drug status from the FDA (Food and Drug Administration) and FDA/EMA (European Medicines Agency) respectively.
Medicenna also develops MDNA209, an IL-2 antagonist for autoimmune diseases; and MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis. Furthermore, the Company develops MDNA132, an IL-13 agonist to treat solid tumors, and IL 13Ralpha2 chimeric antigen receptor T cell. Moreover, Medicenna Therapeutics develops MDNA57 for solid tumors and on-malignant cells of the tumor micro-environment; and MDNA109, an IL-2 agonist to treat cancer immunotherapies.
At the end of July, Medicenna Therapeutics announced the selection of MDNA19 (previously, MDNA109-LA1) as its second immuno-oncology clinical candidate for the treatment of cancer. MDNA19 is a best-in-class long-acting IL-2 developed from the Company's Superkine platform that has shown a unique ability to selectively stimulate cancer killing immune cells without the limitations seen with other long-acting IL-2 programs. Medicenna Therapeutics expects to commence clinical trials with MDNA19 in 2020.
Last week, Medicenna Therapeutics reported financial results for the three months ended June 30, 2019. The Company had a cash balance of $1,057,504 at June 30, 2019. On July 9, 2019, it announced receipt of US$1.9 million in non-dilutive funding from CPRIT, providing Medicenna Therapeutics with roughly $3,530,000 in cash available at June 30, 2019 including these funds. The funds available are sufficient to complete the MDNA55 Phase 2b clinical study and planned End of Phase 2 meeting with the FDA. The Company also has access to another US$1.4 million from the CPRIT grant.
Medicenna Therapeutics Corp. (MDNAF), closed Monday's trading session at $1.0252, even for the day, on 150 volume. The average volume for the last 3 months is 29,671 and the stock's 52-week low/high is $0.505580008/$1.74.
Anvia Holdings Corporation (ANVV)
Stock Target Advisor, GlobeNewswire, MarketWatch, Barchart, Simply Wall St, GuruFocus, Stockhouse, Trading View, Market Screener, Last10k, Stockwatch, Wallet Investor, Dividend Investor, and InvestorsHub reported beforehand on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Anvia Holdings Corporation is an international technology for self and business improvement company. It has acquired and developed a number of proprietary software, mobile applications, learning and educational tools to help consumers and businesses improve and grow. The Company’s mission is to make personal and business growth accessible and sustainable.
The Company was previously known as Dove Street Acquisition Corporation. It changed its name to Anvia Holdings Corporation in January of 2017. Founded in 2016, Anvia Holdings is headquartered in Glendale, California.
The Anvia business and organizational portfolio comprises software and mobile application technologies, consulting services, coaching services, and blended learning content and activities. Some of the areas it serves its business clients are Strategy Management, Competency Management, Performance Management, Learning Management, Customer Experience Management, Franchise, Corporate Advisory and Listing, and HR Information Systems.
Last week, Anvia Holdings announced that it executed a definitive agreement to acquire all of the issued and outstanding shares of XSEED Pty Ltd, an Australian Registered Training Organization. With this agreement, Anvia Holdings, via its fully-owned subsidiary Anvia (Australia) Pty Ltd shall acquire 100 percent of XSEED Pty Ltd outstanding shares for approximately USD 352,000 (AUD 500,000). XSEED engages in the provision of vocational education training (VET) and offers courses that are for the Automotive and Hairdressing industries.
Anvia (Australia) Pty Ltd Chief Executive Officer, Mr. James Kennett, said “Adding XSEED to our education services portfolio solidifies our position in Australia as a major player in Education Services. In addition, XSEED will diversify our current CRICOS and Corporate learning income with further revenue sources.”
Moreover, last week, Anvia Holdings announced it filed an application to list its common shares on the NASDAQ Capital Market. Ali Kasa, Chief Executive Officer and President of Anvia Holdings, said, “The listing of our common shares on NASDAQ would reflect the progress we are making to strengthening our corporate governance and mark another significant milestone in our quest to become a global leader in the self and business improvement industry.”
Anvia Holdings Corporation (ANVV), closed Monday's trading session at $0.59, up 73.5294%, on 2,900 volume with 3 trades. The average volume for the last 3 months is 38,097 and the stock's 52-week low/high is $0.50999999/$6.00.
ZIVO Bioscience, Inc. (ZIVO)
Wallet Investor, Pink Investing, StockInvest.us, Zacks, Equity Clock, OTC Markets, RedChip, Marketbeat, Street Insider, Business Insider, Ceocast News, MarketWatch, Marketwired, and Stockhouse reported previously on ZIVO Bioscience, Inc. (ZIVO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ZIVO Bioscience, Inc.’s commitment is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. ZIVO also engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. OTCQB-listed, ZIVO Bioscience has its corporate headquarters in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.
ZIVO Bioscience is a biotech/agtech R&D company re-inventing itself as a licensor of internally developed intellectual property (IP) that includes its proprietary algae cultures, in addition to IP secured via strategic acquisitions. The Company works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form.
More recently, ZIVO has continued to focus almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass.
The Company’s core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. ZIVO’s plan is to approach the near-term markets first - animal applications, human food ingredients, as well as human dietary supplements.
This past December, ZIVO Bioscience announced that preliminary data analysis from its most recent poultry nutritional efficacy study show positive results that confirm the successes of prior poultry efficacy studies conducted in partnership with NutriQuest, an international innovator in animal nutrition. The 5,000-bird study confirms that pelleted feed containing ZIVO algal biomass consumed in sufficient quantity results in birds exhibiting improved health indicators.
Recently, ZIVO Bioscience announced the issuance of US patent No. 10,161,928 - Wellness Panel - on December 25, 2018. The patent describes the novel use of urinary biomarkers to measure metabolic efficiency and vitality, rather than attempting to use standard medical diagnostics to measure healthiness.
ZIVO Bioscience, Inc. (ZIVO), closed Monday's trading session at $0.092, up 19.4805%, on 12,170 volume with 4 trades. The average volume for the last 3 months is 67,863 and the stock's 52-week low/high is $0.0401/$0.189999997.
Almost Never Films, Inc. (HLWD)
Street Insider, InvestorsHub, PR Newswire, Ticker Report, Penny Stock Hub, OTC Markets, The Street, YCharts, Barchart, Simply Wall St, Dividend Investor, Street Insider, Market Exclusive, MarketWatch, Marketbeat, and Equity Clock reported beforehand on reported beforehand on Almost Never Films, Inc. (HLWD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Almost Never Films, Inc. is an independent film company headquartered in Los Angeles, California. The Company’s emphasis is on film production, finance and production related services for movies under budgets of $35 million. Its business is to enable relationships between creative talent and companies who produce, finance and distribute motion pictures. Almost Never Films’ shares trade on the OTC Markets.
Almost Never Films’ goal is to create, acquire, or license rights to materials upon which it believes motion pictures can be based (screenplays, books, short stories, etc.). The Company has a strategic partnership with Pure Flix Entertainment. This partnership is a multi-film financing agreement to produce six faith-based original motion pictures.
Pure Flix Entertainment is a U.S. independent Christian film and television studio, based in Scottsdale, Arizona. Pure Flix Entertainment will distribute the films globally in new media format. Almost Never Films will contribute its financial, development, and production services.
Almost Never Films previously announced the release of its two faith-based films "The Prayer Box" and "Christmas Manger" (formerly named "Bethlehem Ranch") by Universal Pictures Home Entertainment, the home video distribution division of Universal Pictures. The launch of these two films marks the completion of the first two films of a multi-film financing agreement between Almost Never Films and Pure Flix Entertainment.
This past December, Almost Never Films announced that ION Television acquired the Company's holiday feature "Country Christmas Album". The network aired the film during 2018's holiday season. ION Television is a foremost family-oriented entertainment network. ION Television is a top 10-ranked U.S. general entertainment network. It is the flagship of the independent, privately held media company, ION Media. ION Media's 70 full-power stations reach 102 million homes.
The people behind Almost Never Films are originally from the finance industry. The Company is made up of private equity and investment professionals that have a passion for motion pictures.
Almost Never Films, Inc. (HLWD), closed Monday's trading session at $1.00, up 25.00%, on 4,759 volume with 9 trades. The average volume for the last 3 months is 3,215 and the stock's 52-week low/high is $0.249899998/$2.50999999.
NewBridge Global Ventures, Inc. (NBGV)
Spotlight Growth, OTC Markets, Proactive Investors, GuruFocus, Stockhouse, Dividend Investor, Simply Wall St, 4-Traders, Morningstar, Infront Analytics, Stockflare, Penny Stock Hub, OTC Stock Picks, Central Charts, Wallet Investor, MarketWatch, InvestorsHub, and Investors Hangout reported earlier on NewBridge Global Ventures, Inc. (NBGV), and today we report on the Company, here at the QualityStocks Daily Newsletter.
NewBridge Global Ventures, Inc. concentrates on the developing legal and regulated cannabis industry. It provides business consulting services to companies operating within the legal medical cannabis and hemp related industries. The Company formerly went by the name NABUfit Global, Inc. It changed its corporate name to NewBridge Global Ventures, Inc. in December 2017. OTCQB-listed, NewBridge Global Ventures is based in Alameda, California.
The Company acquires and currently operates a vertically integrated portfolio of California cannabis and hemp companies. NewBridge’s vertical structure includes genetics, cloning, cultivation, manufacturing, distribution, and consulting services to industry entrepreneurs, and education for medical professionals. The Company focuses on compliance, industry best practices, standardization, as well as corporate governance.
NewBridge Global Ventures engages in management consulting and control and non-control acquisitions in the legal cannabis sector and its diverse verticals. The Company’s mission focuses on the global education of healthcare professionals and institutions, international producers, processors, and distributors, and ancillary/supporting technologies that can impact the globalal healthcare and wellness industries.
NewBridge Global Ventures’ portfolio "eco-system" consists of education, production and distribution companies. Its portfolio includes Elevated Education (EE); Roots of Cali; The Bay Clonery; 5Leaf; GENUS Consulting; Green Thumb Distributors; Mad Creek Farm; East 10th Street; East 11th Street; and Timothy.
This month, NewBridge Global Ventures, announced that it expanded its corporate management team with the appointments of Dr. John MacKay as Chief Technology Officer (CTO), Mr. Patrick P. Tang as Chief Compliance Officer (CCO), and Ms. Sandra Ribble as Corporate Controller of NewBridge Global Ventures.
Mr. Bob Bench, NewBridge Global Ventures’ Interim President, said, “NewBridge Global Ventures is building a world class executive team to ensure that we continue to operate at the highest quality and compliance standards in the highly regulated cannabis industry. With ten operating subsidiaries in our vertically integrated corporate structure, it was important to add highly experienced professionals such as John, Pat, and Sandra to oversee technology, compliance and financial governance, key areas for excellence as we continue to scale our operations.”
NewBridge Global Ventures, Inc. (NBGV), closed Monday's trading session at $0.28, up 16.6667%, on 19,000 volume with 6 trades. The average volume for the last 3 months is 12,915 and the stock's 52-week low/high is $0.208000004/$2.50.
Esports Entertainment Group, Inc. (GMBL)
Stockrow, Real Pennies, Dividend Investor, Proactive Investors, Capital Network, Infront Analytics, YCharts, OTC Markets, RedChip, Marketbeat, TradingView, Capital Cube, and Wallet Investor reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business especially focused on esports wagering. Its plan is to offer wagering on esports events in a fully licensed, regulated, and secured platform to the global esports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua, and Barbuda.
Last week, Esports Entertainment Group announced the hiring of two key executives and the opening of its new international headquarters in Malta. Malta was selected because of its strategic location within the European Union (EU), and also access to a highly educated and multi-lingual workforce, particularly in the fields of online gambling.
The Company’s plan is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.
Esports Entertainment is a licensed online gambling business with a particular emphasis on esports wagering and 18+ gaming. The Company’s online esports gambling platform will be completely licensed and the highest regulated esports gambling site worldwide.
The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from centers in Canada and Antigua.
Esports Entertainment has an agreement with PartnerMatrix. This is the first platform that enables online sportsbook and casino operators to run Affiliate System with Agent functionality and Agent System with Affiliate functionality. With the agreement, Esports Entertainment Group will integrate the PartnerMatrix platform to manage its affiliate program on an expedited basis. Esports Entertainment Group has also launched vie.gg. This is the world’s first and most transparent esports betting exchange.
Last month, Esports Entertainment Group announced Affiliate Marketing Agreements with 14 more esports teams as it continues to ramp up affiliate marketing activities in support of its launch of vie.gg. The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5, 2018.
Esports Entertainment Group, Inc. (GMBL), closed Monday's trading session at $0.499, up 17.1362%, on 8,996 volume with 8 trades. The average volume for the last 3 months is 19,782 and the stock's 52-week low/high is $0.263999998/$0.973999977.
First Foods Group, Inc. (FIFG)
Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.
First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.
First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.
First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities.
Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.
First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.
First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.
First Foods Group, Inc. (FIFG), closed Monday's trading session at $0.41, up 17.1429%, on 10,500 volume with 4 trades. The average volume for the last 3 months is 9,673 and the stock's 52-week low/high is $0.050999999/$0.479999989.
Cell Source, Inc. (CLCS)
InvestorsHub and OTC Markets reported on Cell Source, Inc. (CLCS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cell Source, Inc. is a Biotechnology Company listed on the OTC Markets Group’s OTCQB. The Company concentrates on developing cell therapy treatments established on immunotherapy and regenerative medicine. Its principal product is the Veto-Cell immune system management technology. Cell Source has its headquarters in New York, New York.
Cell Source’s Veto-Cell immune system management technology is an immune tolerance biotechnology. It enables the selective blocking of immune responses. The Company’s Veto-Cell technology is utilized in varied applications. These include bone marrow transplantation, veto-cell in transplantation, anti-cancer, and also non-malignant diseases.
The patented Veto-Cell technology addresses one of the most fundamental challenges in human immunology. This challenge is: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.
Veto cells disable the attack of the immune system on the bone marrow transplantation (BMT) only, without other side effects. The Veto cells act as “decoys” that attract, and then kill, the T-cell clones directed at the transplant.
The Veto cells continue “on guard” in the body for lengthy periods of time to further limit rejection. Therefore, the transplantation is accepted by the body without compromising the rest of the immune system.
The principal goal in developing Veto Cells is to have a meaningful and potentially widespread impact on the field of bone marrow and major organ transplantation. In addition, Veto Cells can be combined with other cell therapy treatments to improve their effectiveness. In preclinical studies, Veto Cells have been shown to increase efficacy and persistence of genetically modified cells.
Along with its Veto Cells technology, Cell Source has its Megadose Drug Combination technology. The method of action includes stem cells overcoming rejection by outnumbering immune rejecting cells, and drugs reduce the need for immune suppression.
The Company has a substantial Intellectual Property (IP) Portfolio, exclusively licensed to it from the Weizmann Institute of Science by way of Yeda Research and Development Company Ltd. covering Dr. Yair Reisner’s technologies.
Dr. Yair Reisner is former Chairman of the Department of Immunology of Israel’s Weizmann Institute of Science. He pioneered “mismatched” BMT (partial versus full donor/recipient match) with his patented “Megadose” cell therapy treatment.
In essence, Cell Source’s corporate mission is to transform the fields of transplantation, cancer treatment, and reversal of vital organ disease, using its pioneering immune tolerance and organ regeneration technologies.
Cell Source, Inc. (CLCS), closed Monday's trading session at $0.82, up 26.1538%, on 20,427 volume with 13 trades. The average volume for the last 3 months is 3,740 and the stock's 52-week low/high is $0.301999986/$1.48000001.
The QualityStocks Company Corner
- Youngevity International, Inc. (NASDAQ: YGYI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
- City View Green Holdings Inc. (CSE: CVGR)
- INmune Bio Inc. (NASDAQ: INMB)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- Grapefruit Boulevard Investments Inc. (IGNG)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, announced that it has been awarded a supply partnership with the city of Hialeah's municipal services. With a population of almost 240,000, the city is serviced by more than 30 local government establishments. The partnership includes all government departments located at the City of Hialeah's Palm Avenue offices which include the Mayor's office, the License and Tax Departments, and Finance, HR, and Purchasing Departments. Additionally, CLR's Branded Coffees will be served at the Parks and Recreations Department, Water and Sewer Operations, all 8 Fire Stations, and all 5 Police Department locations.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed Monday's trading session at $5.05, up 0.59761%, on 49,757 volume with 516 trades. The average volume for the last 3 months is 99,073 and the stock's 52-week low/high is $3.56999993/$16.25.
- CLR Roasters Completes Municipal Partnership with One of Florida's Largest Cities
- Youngevity International Inc. (NASDAQ: YGYI) Adds Pet Chews to HEMP FX Line, Brand Featured in Forbes Article
- Youngevity International, Inc. (YGYI) to Release 2019 Second Quarter and Six-Month Results and Host Conference Call to Review Financial Statements and Provide Corporate Update
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in the 420 with CNW by CannabisNewsWire. Nearly all people learn how to make marijuana edibles through personal experiments that have their fair share of “trial and error.” However, there are a number of common mistakes that you can be on guard for as you venture into your journey of marijuana culinary delight. The following are some tips to help you stay clear of making many mistakes.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $2.69, up 3.9252%, on 599,455 volume with 840 trades. The average volume for the last 3 months is 513,239 and the stock's 52-week low/high is $1.60699999/$7.89379978.
- 420 with CNW – 4 Mistakes You Should Avoid While Making Marijuana Edibles
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Named Among Greenest Cannabis Firms, Renews Health Canada Licenses
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Submits Application for NASDAQ Listing
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its class A subordinated voting shares (the "Subordinated Voting Shares") on the TSX. Also today, the company was highlighted in today's edition of Investorideas.com potcastsCM. Listen to the podcast: http://ibn.fm/4yxMP.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $1.87, up 4.85%, on 207,794 volume with 431 trades. The average volume for the last 3 months is 105,571 and the stock's 52-week low/high is $1.73950004/$7.30155992.
- Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move
- Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was featured today in the 420 with CNW by CannabisNewsWire.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.95, up 7.5573%, on 804,555 volume with 680 trades. The average volume for the last 3 months is 317,204 and the stock's 52-week low/high is $0.850000023/$2.03999996.
- 420 with CNW – 4 Mistakes You Should Avoid While Making Marijuana Edibles
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Focuses on Europe, Launches Supreme Heights in London
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Developing Diverse Portfolio of Flourishing Cannabis Brands
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) is excited to announce that BC’s Liquor and Cannabis Regulation Branch has issued a Cannabis Retail Store license to City Cannabis Co’s 2317 Cambie Street location and their Comox Valley location on Vancouver Island. Wildflower recently acquired City Cannabis Co and with their third and fourth locations in B.C. City Cannabis is at the forefront of the BC retail cannabis market.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Monday's trading session at $0.3639, up 13.4369%, on 8,229 volume with 17 trades. The average volume for the last 3 months is 317,204 and the stock's 52-week low/high is $0.009999999/$1.12999999.
- City Cannabis Opens Two New Premier Cannabis Retail Locations in British Columbia
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products
- 420 with CNW – Study Looks at How Marijuana Extracts Can Kill Cancer Cells
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF) is pleased to announce that it will be demonstrating the Uniden® UV350 integrated with Motorola WAVE PTT at APCO 2019 in Baltimore, MD, August 12th and 13th, 2019. The Company will be presenting at the Motorola booth #611.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.3549, up 4.3824%, on 29,550 volume with 8 trades. The average volume for the last 3 months is 55,652 and the stock's 52-week low/high is $0.288599997/$0.446249991.
- Siyata Mobile to Demonstrate UV350 Running Motorola WAVE PTT at APCO 2019
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Receipt of $300K Software Supply Contract
- AT&T Workforce Manager and AT&T Enhanced Push-to-Talk Available on Siyata Mobile UV350 In-Vehicle Phablet
City View Green Holdings Inc. (CSE: CVGR)
Toronto-based City View Green Holdings Inc.’s (CSE: CVGR) vision of a purposeful seed-to-retail cannabis network is advancing thanks to the finalization of an agreement securing its operations in a 40,000-square-foot cultivation facility, where it intends to produce a pharmaceutical-grade crop.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Monday's trading session at $0.125, even for the day, on 67,000 volume with 2 trades. The average volume for the last 3 months is 105,580 and the stock's 52-week low/high is $0.0950/$0.5125.
- City View Green Holdings Inc. (CSE: CVGR) Completes Agreement for Cultivation, Extraction Facility
- City View Green Holdings Inc. (CSE: CVGR) Strengthens Executive Team
- City View Green Holdings Inc. (CSE: CVGR) Closes Sale, Leaseback of Brantford Facility
INmune Bio Inc. (NASDAQ: INMB)
INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported its financial results for the second quarter ended June 30, 2019 and is providing a business update for the year-to-date.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Monday's trading session at $6.11, off by 7.8431%, on 41,334 volume with 205 trades. The average volume for the last 3 months is 18,360 and the stock's 52-week low/high is $5.65999984/$11.50.
- INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
- INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
- INmune Bio Inc. (NASDAQ: INMB) Planning Phase II Trial of INB03 as Part of Combination Immunotherapy for Cancer Patients
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., completed a successful large-scale trial of its Eye-Net™ cellular-based accident prevention solution and met all predefined criteria set for its success. More than 8,500 users from across Israel and abroad participated in the trial.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed Monday's trading session at $1.685, off by 0.882353%, on 44,639 volume with 180 trades. The average volume for the last 3 months is 532,979 and the stock's 52-week low/high is $0.697000026/$3.16000008.
- Eye-Net Mobile Completes Successful Large-Scale Trial of Cellular-Based Accident Prevention Solution
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Releases Q2 and First Half 2019 Financial Results
- Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
Nabis Holdings Inc. (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“NabisTM” or the “Company”), a Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has entered into a Definitive Agreement for the acquisition of 100% of the membership units of a licensed medical marijuana business in the state of Arizona (“The Asset”).
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."
While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.
Criteria for investment targets are as follows:
- Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
- Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
- Identifying proven operators with good expertise to add value to a consolidation strategy
- Focused on MSOs (Multi-state Operators) with strong brand traction
- Pharma grade cultivation, extraction, dispensaries and other addressable operations
Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.
Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.
Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.
Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.
Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.
Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.
Proven Management Team
CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.
President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.
Nabis Holdings (OTC: NABIF), closed Monday's trading session at $0.195, off by 8.4636%, on 85,950 volume with 34 trades. The average volume for the last 3 months is 47,686 and the stock's 52-week low/high is $0.119249999/$0.791499972.
- Nabis Holdings Signs Definitive Agreement to Acquire Vertically Integrated Assets in Arizona
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters World’s Largest Cannabis Industry Market through Acquisition of California Dispensary
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters California Cannabis Market with Dispensary in Southern Desert
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) announced the finalization of its acquisition of 50 percent of the operating rights and interests pertaining to oil sands in the state of Utah under the U.S. federal oil and gas leases. The acquisition encompasses 8,480 gross acres, or 4,240 net acres. All of the shares issued pursuant to the transaction will be subject to a four-month hold period, according to a company news release (http://nnw.fm/mq9Qj).
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.1508, off by 5.2049%, on 200,250 volume with 42 trades. The average volume for the last 3 months is 254,480 and the stock's 52-week low/high is $0.130500003/$1.39999997.
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Finalizes Resource Acquisition in Utah
- NetworkNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Obtains Licensing Contract for Proprietary Clean-Surface, Oil-Extraction Technology
Grapefruit Boulevard Investments Inc. (IGNG)
Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.
The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.
Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.
Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.
Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.
The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.
Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.
The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.
Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.
Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.
Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.
Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:
- Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
- Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.
Grapefruit Boulevard Investments Inc. (IGNG), closed Monday's trading session at $0.0799, up 0.250941%, on 91,048 volume with 28 trades. The average volume for the last 3 months is 139,993 and the stock's 52-week low/high is $0.006095/$0.358999997.
- Grapefruit Boulevard Investments Inc. (IGNG) Launches “Rainbow Dreams” – A New Line of Flavored CBD THC Oil Infused Vaporization CCell Cartridges
- Grapefruit Boulevard Investments Inc. (IGNG) Files Registration Statement, Anticipates Funding of Second Tranche
- Imaging3, Inc./Grapefruit Announces Filing of Registration Statement
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Monday's trading session at $0.2089, up 11.2946%, on 11,091 volume with 11 trades. The average volume for the last 3 months is 139,993 and the stock's 52-week low/high is $0.173800006/$0.605000019.
- 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- 420 with CNW – Church of England Starts Investing in Marijuana
- 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Monday's trading session at $0.125, up 13.6364%, on 230,978 volume with 77 trades. The average volume for the last 3 months is 330,894 and the stock's 52-week low/high is $0.035999998/$0.634559988.
- IONIC BRANDS Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s Illinois Dispensaries
- Cannabis Edibles Market Projected to Quadruple in U.S. and Canada to $4.1 Billion
- Ionic Brands Completes Acquisition of Zoots - Premium Cannabis-Infused Edibles and Infused Products
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Issuance, Sale of Additional Shares Per Exercise of Underwriter’s Over-Allotment Option in IPO
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Texas State Police Memo Instructs Officers to Stop Cannabis Possession Arrests
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- ChineseInvestors.com (CIIX) Board of Directors Appoints Shelby Chan as it's Newest Independent Director
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Strengthens Executive Team
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Subsidiaries Heighten Global CBD Presence
- Endonovo Therapeutics (OTCQB: ENDV) Positioning SofPulse as Natural Post-Surgical Alternative to Opioids
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Releases Q2 and First Half 2019 Financial Results
- Genprex Inc. (NASDAQ: GNPX) Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex Clinical Development Program
- Geyser Brands Inc. (TSX.V: GYSR) CBD Pet Care: One of the Fastest Growing Wellness Market Segments
- Golden Developing Solutions, Inc. (DVLP) Attains Fully Reporting Status
- Grapefruit Boulevard Investments Inc. (IGNG) Launches “Rainbow Dreams” – A New Line of Flavored CBD THC Oil Infused Vaporization CCell Cartridges
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) It Appears Consumers Preferences are Shaping the Retail Cannabis Market’s Direction
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Oregon Law Forbids the Sale of Marijuana Byproducts
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- INmune Bio, Inc. (NASDAQ: INMB) Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s Illinois Dispensaries
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Completes Initial Project with Canada's National Research Council
- Marijuana Company of America Inc. (MCOA) Announces Virtual Launch Party of Cannabis Delivery Service VivaBuds
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Florida Personal Injury Lawyer Turns Around and Decides to Back Marijuana Legalization Drive
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters World’s Largest Cannabis Industry Market through Acquisition of California Dispensary
- Nightfood, Inc. (OTCQB: NGTF) Sports Influencers and Consumer Branding - It's a Win-Win
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Conditional Approval to Uplist to the TSX
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) 420 with CNW – Luxembourg Reveals Intention to Become First in Europe to Legalize Marijuana
- Pressure BioSciences Inc. (PBIO) Solves CBD Water-Solubility Problem with Patented UST Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Revolutionizing Direct-Selling Industry
- SinglePoint, Inc. (SING) President Discusses Rapidly Growing CBD Business on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Receipt of $300K Software Supply Contract
- Spectrum Global Solutions, Inc. (SGSI) Targets Growing Demands of $1.5 Trillion Telecommunications Market
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Colorado Nurses to Launch Cannabis Information Hotline
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Files Preliminary Economic Assessment and Updated Mineral Resource Technical Report for Its Southern Arkansas Lithium Brine Project
- Sugarmade, Inc. (SGMD) Enters Kentucky Hemp Boom, Announces Completion of BZRTH Audit
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Pursuing Growth through Partnerships, Added Talent
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Named Among Greenest Cannabis Firms, Renews Health Canada Licenses
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- Trxade Group Inc. (TRXD) Receives SEC Approval, Enhances Transparency
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses
- VPR Brands, LP (VPRB) on Track to be Vaping Market Trailblazer
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Receives Subscriptions for $1,325,000 Convertible Debenture Financing
- Willow Biosciences Inc. (CSE: WLLW) New Cannabis Stocks Added to Investor Ideas
- Youngevity International, Inc. (NASDAQ: YGYI) Adds Pet Chews to HEMP FX Line, Brand Featured in Forbes Article
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.